No abstract available
Keywords:
Crizotinib; EML4-ALK; Gene testing; Partial response; SCLC.
Publication types
-
Case Reports
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adult
-
Carcinoma, Non-Small-Cell Lung / drug therapy*
-
Crizotinib / administration & dosage
-
Crizotinib / pharmacology*
-
Humans
-
Male
-
Oncogene Proteins, Fusion / drug effects*
-
Oncogene Proteins, Fusion / genetics*
-
Protein Kinase Inhibitors / administration & dosage
-
Protein Kinase Inhibitors / pharmacology*
-
Treatment Outcome
Substances
-
EML4-ALK fusion protein, human
-
Oncogene Proteins, Fusion
-
Protein Kinase Inhibitors
-
Crizotinib